ADAM VOGEL to Disease-Free Survival
This is a "connection" page, showing publications ADAM VOGEL has written about Disease-Free Survival.
Connection Strength
0.060
-
Cisplatin and 5-fluorouracil with or without epidermal growth factor receptor inhibition panitumumab for patients with non-resectable, advanced or metastatic oesophageal squamous cell cancer: a prospective, open-label, randomised phase III AIO/EORTC trial (POWER). Ann Oncol. 2020 02; 31(2):228-235.
Score: 0.034
-
Oxaliplatin and 5-FU/folinic acid (modified FOLFOX6) with or without aflibercept in first-line treatment of patients with metastatic colorectal cancer: the AFFIRM study. Ann Oncol. 2016 07; 27(7):1273-9.
Score: 0.026